Toggle navigation
Home
Search
Services
Blog
Contact
About
Pharmaceutical Formulation of Lead Drug Candidates
Murty Pharmaceuticals, Inc., Lexington, KY, United States
See 26 grants from Murty Pharmaceuticals, Inc.
Abstract
Funding
Institution
Comments
Recent in Grantomics:
University of Virginia
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
CRISPR/Cas9-based lineage tracing for fate mapping of cancer cells and stem cells
Mechanisms of Genome Maintenance by Bromodomain Chromatin Reader Proteins
Dual Function of VPO1 in Pathogen Recognition and Killing
Center for Biobehavioral Studies of Fatigue Management
A Database Catalogue of the Termites (Isoptera) of the World
Recently added grants:
Mechanisms of Pheromone-Controlled Lysozyme Resistance and Surface Display of Streptococcus pyogenes
GHESKIO HIV Clinical Trial Unit
Parameters governing infection with BK polyomavirus
Vaccine to prevent E. coli urinary tract infection
A novel system using human fetal brain neural stem cell to model ZIKV infection
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research and Development Contracts (N01)
Project #
271201000010I-0-27100003-1
Application #
8573255
Study Section
Project Start
2012-09-20
Project End
2016-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$334,667
Indirect Cost
Institution
Name
Murty Pharmaceuticals, Inc.
Department
Type
DUNS #
943117366
City
Lexington
State
KY
Country
United States
Zip Code
40509
Comments
Be the first to comment on this grant